Real-World Treatment Patterns and Overall Survival (OS) of Patients with Metastatic Castration-Resistant Prostate Cancer in Italy.

Pragmat Obs Res · 2025 · PMC12619622 · PMID 41244985

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Conclusion This real-world analysis conducted in Italy on mCRPC patients confirmed that CHT is still the most common 1L therapy, although after 2015 and in more recent years, an increasing trend in the use of ARPI, also as entry therapy, has been observed.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.